Trump's generic drug tariff plan raises questions over prices, U.S. manufacturing and which drugmakers stand to gain or lose as details remain unclear.

Trump plans to impose a 100% tariff on imported generic drugs in two years to bolster domestic manufacturing of these widely-used medications.

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. America’s generic drug market is one of our greatest health ...

Replacing high-cost generics with cheaper medications that have the same clinical benefit could have cut down spending and saved patients about 88%, according to Johns Hopkins research published in ...

Pharmaceutical tariff 2026: A 100% import duty on patented drugs and active pharmaceutical ingredients hits 17 major companies including AbbVie, Pfizer, and Novo Nordisk on Friday under Section 232.

Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Specialty Generics Market 2025-2033" report has been added to ResearchAndMarkets.com's offering. The global specialty generics market size reached USD 81 ...

The particularly harsh winter across much of the country has made the last month particularly difficult for those who suffer from asthma. Exacerbating their distress is the fact that the price of ...

The Association for Accessible Medicines’ annual U.S. Generic & Biosimilar Medicines Savings Report, in partnership with the IQVIA Institute, reveals that the use of Food and Drug Administration ...

Recent press reports and other evidence suggest that Medicare Part D plans may be encouraging the use of brand-name drugs instead of generics. However, the scope of such practices is unclear. We ...

India's pharmaceutical sector is beginning to shift from manufacturing generics to developing novel medicines, backed by rising private investment, stronger research and policy support ...